Speech Perception Assessment via Mobile App for Hearing Loss
(VALDE-MU Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a Mobile Research App, known as Cochlear CoPilot, to evaluate its effectiveness in helping people with hearing loss understand speech. The trial examines how well this app works for adults with cochlear implants or hearing aids. Participants will use the app either in a clinic or both at home and in the clinic. Adults who use a hearing device and speak the test language fluently may be suitable for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could improve hearing aid and cochlear implant experiences.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial investigator.
What prior data suggests that this Mobile Research App is safe for measuring speech perception in cochlear implant recipients?
Research shows that the Mobile Research App, used to assess speech comprehension, is safe for humans. No evidence indicates safety problems with this app. It is designed to help people with cochlear implants or hearing aids improve their listening skills. Since the app is used for testing and practice, it poses much less risk than new drugs or medical procedures.
Similar apps, like the Cochlear™ CoPilot, have been used without any reports of problems, suggesting that the Mobile Research App is likely safe and well-tolerated. Participants use it to practice and improve their hearing both in the clinic and at home, offering flexibility and convenience. In summary, research supports the app's safety for users.12345Why are researchers excited about this trial?
Researchers are excited about the Speech Perception Assessment via Mobile App for hearing loss because it offers a new method for delivering therapy using technology. Unlike traditional treatments that require frequent in-person visits to assess and improve hearing, this mobile app allows cochlear implant and hearing aid users to practice speech perception at home. This convenience can lead to more consistent use and potentially better outcomes. Additionally, the app aims to gather data on how well users perceive speech over time, which could help tailor treatments more effectively in the future.
What evidence suggests that the Mobile Research App is effective for assessing speech perception in hearing loss?
Research has shown that mobile apps like Cochlear CoPilot can help people with cochlear implants improve their listening and communication skills. These apps provide information and interactive activities to enhance speech understanding. A study on a similar app found that it aided real-time speech processing and improved hearing techniques. Users reported better hearing through the app's skills training. In this trial, participants will use the Mobile Research App, either in-clinic or both in-clinic and at home, to evaluate its effectiveness in assisting cochlear implant and hearing aid users with speech perception. Although limited data exists on the Mobile Research App specifically, early findings suggest it could effectively aid in speech perception.14678
Are You a Good Fit for This Trial?
This trial is for adults over 18 who use a hearing device, are fluent in the language of the speech perception test, and can consent to participate. It's not for Cochlear employees, those involved in other drug/device trials within 30 days, or pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the Mobile Research App to measure and validate speech perception endpoints
Follow-up
Participants are monitored for speech perception ability and test-retest reliability
What Are the Treatments Tested in This Trial?
Interventions
- Mobile Research App
Mobile Research App is already approved in United States, Canada for the following indications:
- Speech perception assessment for adult cochlear implant recipients
- Speech perception assessment for adult cochlear implant recipients
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cochlear
Lead Sponsor
Dig Howitt
Cochlear
Chief Executive Officer since 2018
BE (Hons), MBA
Michael del Prado
Cochlear
Chief Medical Officer since 2022
MD, MSc, FRACP, FAAHMS, FAICD